PH30129A - Sertindole prodrug compositions and use - Google Patents

Sertindole prodrug compositions and use

Info

Publication number
PH30129A
PH30129A PH43225A PH43225A PH30129A PH 30129 A PH30129 A PH 30129A PH 43225 A PH43225 A PH 43225A PH 43225 A PH43225 A PH 43225A PH 30129 A PH30129 A PH 30129A
Authority
PH
Philippines
Prior art keywords
sertindole
group
iii
optionally substituted
nr2r3
Prior art date
Application number
PH43225A
Other languages
English (en)
Inventor
Jens Kristian Perregaard
Henrik Pedersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of PH30129A publication Critical patent/PH30129A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
PH43225A 1990-10-03 1991-10-01 Sertindole prodrug compositions and use PH30129A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK238190A DK238190D0 (da) 1990-10-03 1990-10-03 Depotderivater

Publications (1)

Publication Number Publication Date
PH30129A true PH30129A (en) 1997-01-21

Family

ID=8111993

Family Applications (1)

Application Number Title Priority Date Filing Date
PH43225A PH30129A (en) 1990-10-03 1991-10-01 Sertindole prodrug compositions and use

Country Status (20)

Country Link
US (1) US5428036A (fr)
EP (1) EP0592433B1 (fr)
JP (1) JP3100980B2 (fr)
KR (1) KR100212430B1 (fr)
AT (1) ATE175964T1 (fr)
AU (1) AU652783B2 (fr)
CA (1) CA2093433C (fr)
DE (1) DE69130803T2 (fr)
DK (2) DK238190D0 (fr)
ES (1) ES2125870T3 (fr)
FI (1) FI102679B (fr)
GR (1) GR3029399T3 (fr)
IE (1) IE913384A1 (fr)
IL (1) IL99652A (fr)
NO (1) NO301475B1 (fr)
NZ (1) NZ240051A (fr)
PH (1) PH30129A (fr)
PT (1) PT99142B (fr)
WO (1) WO1992006089A1 (fr)
ZA (1) ZA917881B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
NZ243065A (en) 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK206591D0 (da) * 1991-12-23 1991-12-23 Lundbeck & Co As H Behandling af psykoser
JPH0625964U (ja) * 1992-05-25 1994-04-08 ミクロン機器株式会社 通信機能付きコインカウンタ及び有料装置
US6489341B1 (en) * 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
EP1423107B1 (fr) 2001-03-23 2012-05-09 Luitpold Pharmaceuticals, Inc. Conjugues d'agents pharmaceutiques et d'alcools gras
JP2005500988A (ja) * 2001-03-23 2005-01-13 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪族アミン薬物複合体
EP2129663A2 (fr) * 2007-02-28 2009-12-09 Ranbaxy Laboratories Limited Antagonistes des récepteurs muscariniques
CA2937222C (fr) 2009-06-25 2019-06-04 Alkermes Pharma Ireland Limited Promedicaments de composes nh acides
EP2445502B2 (fr) 2009-06-25 2022-09-28 Alkermes Pharma Ireland Limited Composés hétérocycliques destinés au traitement de troubles neurologiques et psychologiques
ES2691671T3 (es) 2010-06-24 2018-11-28 Alkermes Pharma Ireland Limited Profármacos de compuestos NH-acídicos: derivados de éster, carbonato, carbamato y fosfonato
CN112423754A (zh) 2018-03-05 2021-02-26 奥克梅斯制药爱尔兰有限公司 阿立哌唑的给药策略

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3408356A (en) * 1965-08-31 1968-10-29 Squibb & Sons Inc Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like
US4038305A (en) * 1972-03-20 1977-07-26 Aktieselskabet Grindstedvaerket Cyclopentenone derivatives
GB1469108A (en) * 1973-06-25 1977-03-30 Kefalas As Thiaxanthene derivative
JPS568318A (en) * 1979-06-28 1981-01-28 Janssen Pharmaceutica Nv Non oral long acting composition of haloperidol and bromperidol derivative
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8621892D0 (en) * 1986-09-11 1986-10-15 Lundbeck & Co As H Organic compound
GB8908085D0 (en) * 1989-04-11 1989-05-24 Lundbeck & Co As H New therapeutic use
DE3921886A1 (de) * 1989-07-04 1991-01-17 Wolfgang Mohr Vorrichtung zum schneiden von gestapeltem, blattfoermigen gut

Also Published As

Publication number Publication date
GR3029399T3 (en) 1999-05-28
PT99142B (pt) 1999-04-30
US5428036A (en) 1995-06-27
ZA917881B (en) 1992-07-29
NO301475B1 (no) 1997-11-03
DK238190D0 (da) 1990-10-03
CA2093433C (fr) 2000-11-21
KR100212430B1 (ko) 1999-08-02
FI102679B1 (fi) 1999-01-29
IL99652A0 (en) 1992-08-18
ES2125870T3 (es) 1999-03-16
DE69130803D1 (de) 1999-03-04
ATE175964T1 (de) 1999-02-15
FI102679B (fi) 1999-01-29
HK1009273A1 (en) 1999-05-28
AU8710491A (en) 1992-04-28
JPH06501939A (ja) 1994-03-03
IE913384A1 (en) 1992-04-08
PT99142A (pt) 1994-02-28
NO931219D0 (no) 1993-03-31
KR930702335A (ko) 1993-09-08
EP0592433A1 (fr) 1994-04-20
FI931472A0 (fi) 1993-04-01
DE69130803T2 (de) 1999-08-19
FI931472A7 (fi) 1993-04-01
AU652783B2 (en) 1994-09-08
EP0592433B1 (fr) 1999-01-20
WO1992006089A1 (fr) 1992-04-16
JP3100980B2 (ja) 2000-10-23
NZ240051A (en) 1993-05-26
DK0592433T3 (da) 1999-09-13
CA2093433A1 (fr) 1992-04-04
NO931219L (no) 1993-04-01
IL99652A (en) 1997-04-15

Similar Documents

Publication Publication Date Title
PH30129A (en) Sertindole prodrug compositions and use
IL104305A0 (en) Piperazine derivatives,their preparation and pharmaceutical compositions containing them
ATE25251T1 (de) Anti srs-a carbonsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische formulierungen.
ES8306141A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo
ZA82567B (en) Process for the preparation of 2-penem compounds,novel 2-penem compounds produced thereby,and pharmaceutical compositions containing them
HU913392D0 (en) Amino-glycoside substance with decreased nephrotoxicity
ATE14579T1 (de) Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen.
NZ240050A (en) Substituted piperazine derivatives; pharmaceutical compositions and preparatory processes
SG76479A1 (en) Pleuromutilin derivatives
BG100717A (en) 1,3-oxazin-4-one derivatives, process and intermediates for their preparation and their use
DE69628750D1 (de) Neue antivirale, homocarbozklische nukleosidderivate von substituierten pyrimidindionen, verfahren zu ihrer herstellung und zusammensetzungen, die diese als aktiven bestandteil enthalten
ES8200323A1 (es) Procedimiento de preparacion de esteres de derivados de la aletrolona y de acidos ciclopropeno-carboxilicos
ES466682A1 (es) Procedimiento para la obtencion de derivados del acido inde-no - 2.1-b-tiopen-2-oxamico
ES8301479A1 (es) Un procedimiento para la preparacion de antibioticos de b-lactama.
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES485492A1 (es) Un procedimiento para preparar derivados de triazol
ATE36520T1 (de) Polyprenylverbindung, ihre herstellung und pharmazeutische verwendung.
HUT53638A (en) Process for producing 15-amino-substituted 20,21-dinoreburnamenie derivatives and pharmaceutical compositions containing them
ATE186907T1 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung
ES8200112A1 (es) Un procedimiento para la preparacion de un derivado del aci do clavulanico.
ATE22683T1 (de) Substituiertes heterocyclylphenylsulphonyl und phosphonylamidine, verfahren zu deren herstellung und deren pharmazeutische anwendung.